Literature DB >> 23387809

Bilateral wilms tumor with TP53-related anaplasia.

Sergey D Popov1, Gordan M Vujanic, Neil J Sebire, Tasnim Chagtai, Richard Williams, Sucheta Vaidya, Kathy Pritchard-Jones.   

Abstract

Wilms tumor (WT) with diffuse anaplasia has an unfavorable prognosis and is often (>70%) associated with mutations in the TP53 gene. Although most WTs are unilateral, 5-10% are bilateral, and they are almost always present with nephrogenic rests. The latter are considered a precursor of WT. Two cases of bilateral WTs with nephroblastomatosis, in which anaplastic changes were detected over a period of time, were analyzed using clinical, radiological, histopathological, and molecular-genetic data. TP53 was analyzed by direct sequencing of its full coding sequence and intron-exon boundaries in 11 fragments. DNA was extracted from paraffin-embedded or frozen specimens. High-resolution genomic copy number profiling was carried out by UCL Genomics on the Affymetrix Human Mapping 250K Nsp or Genome-Wide Human SNP Array 6.0 platform. Both cases demonstrated a strong association between the appearance of anaplastic clones and TP53 mutations. Synchronous ganglioneuroma was diagnosed in one case. Our cases are unique as they represent a long disease history and demonstrate the difficulties in managing rare cases of bilateral WT with anaplasia. These cases also emphasize the practical importance of modern molecular-genetic techniques and their clinical application. Moreover, they highlight the issue of the adequate sampling needed in order to gather comprehensive, efficient, and sufficient information about genetic events in a single tumor.

Entities:  

Mesh:

Year:  2013        PMID: 23387809     DOI: 10.2350/12-08-1245-CR.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  4 in total

Review 1.  Wilms' tumor: biology, diagnosis and treatment.

Authors:  Elwira Szychot; John Apps; Kathy Pritchard-Jones
Journal:  Transl Pediatr       Date:  2014-01

2.  Multiple mechanisms of MYCN dysregulation in Wilms tumour.

Authors:  Richard D Williams; Tasnim Chagtai; Marisa Alcaide-German; John Apps; Jenny Wegert; Sergey Popov; Gordan Vujanic; Harm van Tinteren; Marry M van den Heuvel-Eibrink; Marcel Kool; Jan de Kraker; David Gisselsson; Norbert Graf; Manfred Gessler; Kathy Pritchard-Jones
Journal:  Oncotarget       Date:  2015-03-30

Review 3.  Bilateral Wilms tumour: a review of clinical and molecular features.

Authors:  Jocelyn Charlton; Sabine Irtan; Christophe Bergeron; Kathy Pritchard-Jones
Journal:  Expert Rev Mol Med       Date:  2017-07-18       Impact factor: 5.600

4.  Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications.

Authors:  George D Cresswell; John R Apps; Tasnim Chagtai; Borbala Mifsud; Christopher C Bentley; Mariana Maschietto; Sergey D Popov; Mark E Weeks; Øystein E Olsen; Neil J Sebire; Kathy Pritchard-Jones; Nicholas M Luscombe; Richard D Williams; William Mifsud
Journal:  EBioMedicine       Date:  2016-05-27       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.